First Phase Test of New Thromboxane a 2(TXA2) Receptor Antagonist Z-335.

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.30.225
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Related search

Study on Pharmacodynamics of Thromboxane a 2(TXA2) Synthetase Inhibitor CV-4151 in an Elder Patient.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1994English

Effects of Z-300, a New Histamine H2-Receptor Antagonist, on Mucin Biosynthesis in Rat Gastric Mucosa.

The Japanese Journal of Pharmacology
1994English

PGH2-TxA2-receptor Blockade Restores Vasoreactivity in a New Rodent Model of Genetic Hypertension

Journal of Applied Physiology
MedicinePhysiologySports Science
2000English

Development of a Rat Parathyroid Hormone 2 Receptor Antagonist

Peptides
BiochemistryEndocrinologyPhysiologyCellularMolecular Neuroscience
2007English

Pharmacological Profile of TP-680, a New cholecystokininA Receptor Antagonist

British Journal of Pharmacology
Pharmacology
1996English

A New Type of Cytokine Receptor Antagonist Directly Targeting Gp130

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Experimental Studies on Cerebral Angiospasm. Particularly on the Actions of ONO-3708, a TxA2 Antagonist.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1988English

Thromboxane A2 Synthetase Inhibitors and Thromboxane A2 Receptor Antagonists.

Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry
Organic Chemistry
1987English

Effects of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor 1 and Thromboxane A2 Receptor, on Sephadex-Induced Airway Inflammation in Rats

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy